日勾维肠杆菌中固氮基因表达的调节

用^(32)P中标记的nifHDK和nifA基因探针与日勾维肠杆菌(E.gergoviae 57-7)DNA杂交,证明在E.gergoviae 57-7中存在类似nifHDK及nifA的基因.经接合转移法把nifHpromotor:IacZ融合子引入E.gergoviae 57-7,在转交子中可测到较高的β-半乳糖苷酶活性,表明在E.gergoviae 57-7中类似nifA基因对固氮基因表达的调节特性与K.pneumoniae的类似.载有组成型表达nifA基因的质粒pCK3经接合转移法引入E.gergoviae 57-7,转交子生长速率与野生型相似,在高氨下合成固氮酶并能恢复50%以上的固氮活性.     

核糖核酸酶抑制因子(RI)的融合表达与复性

应用PCR技术从核糖核酸酶抑制因子 (ribonucleaseinhibitor ,RI)的克隆载体pT7 ri中扩增出ri片段 (1 5kb) ,亚克隆到融合表达载体pGEX 2T中 ,并转化感受态大肠杆菌BL2 1.异丙基半乳糖苷 (IPTG)诱导表达的GST RI经SDS PAGE证明分子量约 76kD ,表达量约占菌体蛋白总量 2 0 % .以包涵体形式表达的目的蛋白经尿素变性 ,透析复性得到的产物具有较高的抑制RNaseA的活性(15 0U ml) .复性的融合蛋白于 2 4℃经凝血酶作用 16h ,可被切割成 5 0kD的RI和 2 6kD的GST .     

prbA,a gene coding for an esterase hydrolyzing parabens in enterobacter cloacae and Enterobacter gergoviae strains

The new gene prbA encodes an esterase responsible for the hydrolysis of the ester bond of parabens in Enterobacter cloacae strain EM. This gene is located on the chromosome of strain EM and was cloned by several PCR approaches. The prbA gene codes for an immature protein of 533 amino acids, the first 31 of which represent a proposed signal peptide yielding a mature protein of a putative molecular mass of 54.6 kDa. This enzyme presents analogies with other type B carboxylesterases, mainly of eukaryotic origin. The cloning and expression of the prbA gene in a strain of Escherichia coli previously unable to hydrolyze parabens resulted in the acquisition of a hydrolytic capacity comparable to the original activity of strain EM, along with an increased resistance of the transformed strain to methyl paraben. The presence of homologues of prbA was tested in additional ubiquitous bacteria, which may be causative factors in opportunistic infections, including Enterobacter gergoviae, Enterobacter aerogenes, Pseudomonas agglomerans, E. coli, Pseudomonas aeruginosa, and Burkholderia cepacia. Among the 41 total strains tested, 2 strains of E. gergoviae and 1 strain of Burkholderia cepacia were able to degrade almost completely 800 mg of methyl paraben liter(-1). Two strains of E. gergoviae, named G1 and G12, contained a gene that showed high homology to the prbA gene of E. cloacae and demonstrated comparable paraben esterase activities. The significant geographical distance between the locations of the isolated E. cloacae and E. gergoviae strains suggests the possibility of an efficient transfer mechanism of the prbA gene, conferring additional resistance to parabens in ubiquitous bacteria that represent a common source of opportunistic infections.     

人乳头瘤病毒11型L2NE7E6融合蛋白的原核表达及其诱发的T细胞免疫反应

目的:在原核表达系统中表达人乳头瘤病毒11型(HPV11)L2NE7E6融合蛋白,纯化蛋白后免疫小鼠,检测其诱发的T细胞免疫水平,并筛选HPV11 E6、E7特异的T细胞表位肽。方法:用重叠PCR方法构建HPV11L2NE7E6融合基因并插入原核表达质粒,在大肠杆菌中经IPTG诱导表达融合蛋白L2NE7E6,用SDS-PAGE和West-ern印迹鉴定融合蛋白的表达。Q柱纯化蛋白后免疫C57BL/6小鼠,分别用覆盖HPV11 E6和E7蛋白序列的肽库,采用酶联免疫斑点法(ELISPOT)检测其诱发的E7、E6特异的T细胞免疫反应,并筛选E7、E6特异的T细胞表位肽。结果:在原核表达系统中有效表达了HPV11 L2NE7E6融合蛋白,蛋白纯化后免疫C57BL/6小鼠,分别能检测到针对HPV11 E6、E7肽库刺激产生的特异性T细胞免疫反应。经肽池筛选到1条强的E6 T细胞表位肽E6aa41-55(AEI-YAYAYKNLKVVW);而E7只筛选到2条弱的T细胞表位肽,分别为E7aa53-67(QILTCCCGCDSNVRL)和E7aa73-87(DGDIRQLQDLLLGTL)。结论:HPV11 L2NE7E6融合蛋白能诱发小鼠产生E6、E7特异性细胞免疫反应,可作为尖锐湿疣免疫治疗候选疫苗。     

双报告基因真核表达载体的构建及其功能鉴定

目的:构建绿色荧光蛋白和海肾荧光素酶共同高效表达的双报告基因真核表达载体。方法:将增强型绿色荧光蛋白基因和海肾荧光素酶基因以昆虫病毒T2A序列相连接而后克隆进入pcDNA3.1(-)质粒,构建双报告基因真核表达载体。将该载体转染至COS-7细胞,通过荧光显微镜观察、照度计定量分析检测绿色荧光蛋白和海肾荧光素酶生物活性,Western Bolt检测T2A序列自剪切效率。结果:双报告基因真核表达载体能够同时表达非融合的绿色荧光蛋白和海肾荧光素酶,与单独表达载体产物具有相似的生物活性和表达效率。结论:双报告基因真核表达载体建立成功,为基因表达调控等相关领域研究提供辅助工具。     

IL-1018-57-PE40高效表达、纯化及细胞活性之研究

以IL-10的功能短肽(40肽,即IL-10第18号至57号氨基酸)为导向部分与PE40(绿脓杆菌外毒素除去受体结合区后的剩余部分)融合分别构建了IL-101857PE40的胞质和胞周质表达质粒,其中,IL101857PE40在Rosettablue(DE3)中以高效胞质可溶形式表达,在BL21(DE3)pLysS中以胞周质分泌形式表达;表达宿主菌Rosettablue(DE3)超声波破碎后,依次通过硫酸铵盐析、疏水层析、铜离子亲和层析、阴离子交换层析纯化后,得96%重组毒素纯品;细胞活性实验、细胞ELISA和荧光标记实验表明,构建的IL101857PE40符合免疫毒素的作用机理。因此,该实验为PE免疫毒素的规模制备和纯化做了一定的有益的探索。     

Expression of soybean glycinin subunit precursor cDNAs in Escherichia coli

As the cDNAs encoding A1aB1b and A2B1a subunit precursors of the glycinin A2 subfamily contain a unique NcoI site sequence, (A)CCATGG, occurring at their translation initiation sites, plasmids were constructed to direct the synthesis of those precursor proteins by inserting NcoI/PstI fragments derived from those cDNA clones into the NcoI/PstI-pKK233-2 expression vector in Escherichia coli MV1190, respectively. The resultant plasmids directed the expression of 57-kDa protein components that have molecular masses in agreement with those of the in vitro translation products directed by glycinin A2 subfamily mRNAs, by the addition of isopropyl beta-D-thiogalactoside. These proteins, which comprised as much as 1% of the total bacterial protein, are immunoprecipitable with rabbit antibodies specific for glycinin subunits. This procedure makes glycinin subunits available as a model for studying structure-function relationships in seed proteins using site-directed mutagenesis. This is the first expression of glycinin-like storage protein in E. coli.     

牛γ 干扰素的表达及其抗病毒活性测定

通过RT-PCR从经ConA刺激诱导的奶牛脾脏淋巴细胞总RNA中扩增出牛γ干扰素 (BoIFN-γ) cDNA,克隆到真核载体pVAX1中,测序结果显示pVAX1中的插入序列BoIFN-γ基因与已报道序列一致。用重组质粒pVAX1-BoIFN-γ转染COS-7细胞并进行间接免疫荧光试验鉴定,结果显示BoIFN-γ在COS-7细胞中得到成功表达。将BoIFN-γ基因克隆到原核表达质粒pET-30a(+)、pGEX-6p-1后,分别转化重组表达菌BL21(DE3)、BL21后,通过对表达条件的优化,SDS-P     

鼻咽癌侯选抑瘤基因BRD7原核表达载体的构建及其表达

BRD7基因是一个鼻咽癌侯选抑瘤基因,为了构建BRD7基因的原核表达载体并使其在大肠杆菌得到表达,设计了带有SalⅠ,NotⅠ酶切位点的引物,以已构建好的质粒pGEM-T Easy/BRD7为模板,用PCR扩增出BRD7基因的完整阅读框架,并用SalⅠ,NotⅠ酶切PCR产物和原核表达载体PGEX-4T-2,然后用T4 DNA连接酶将其连接,得到重组表达质粒PGEX-4T-2/BRD7,经双酶切鉴定和测序验证,表达载体构建正确.重组表达质粒转化感受态大肠杆菌Jm105后用IPTG诱导,成功表达了一分子质量约为90 ku的融合蛋白;37℃诱导4 h后,SDS-聚丙烯酰胺凝胶(PAGE)电泳后,经扫描分析该融合蛋白产量占菌体蛋白总量28.48%, 蛋白质印迹(Western-blot)证实了该融合蛋白的表达获得成功.这为BRD7基因的蛋白纯化及抗体制备,进一步开展其功能研究奠定了基础.     

乙型脑炎病毒表达载体的研究

用RT-PCR方法分段扩增了乙型脑炎病毒SA14—14—2疫苗株5′、3′NCR,利用融合PCR技术在5′、3′NCR之间引入BamHⅠ酶切位点,将5′NCR置于T7启动子控制之下,构建乙脑病毒微复制子表达载体pMR。分别将绿色荧光蛋白(GFP)和汉滩病毒核蛋门编码区基因插入到pMR中,构建两种表达外源基因的乙脑病毒微复制子表达载体：pMR—GFP和pMR-84FliS。绎荧光显微镜直接观察、Western blot、ELISA等方法检测,证实外源基因能够在辅助病毒SA14—14—2感染的BHK-21细胞中表达。     

A System for Dual Protein Expression in Pichia pastoris and Escherichia coli

We have constructed a novel Pichia pastoris/Escherichia coli dual expression vector for the production of recombinant proteins in both host systems. In this vector, an E. coli T7 promoter region, including the ribosome binding site from the phage T7 major capsid protein for efficient translation is placed downstream from the yeast alcohol oxidase promoter (AOX). For detection and purification of the target protein, the vector contains an amino-terminal oligohistidine domain (His6) followed by the hemaglutinine epitope (HA) adjacent to the cloning sites. A P. pastoris autonomous replicating sequence (PARS) was integrated enabling simple propagation and recovery of plasmids from yeast and bacteria (1). In the present study, the expression of human proteins in P. pastoris and E. coli was compared using this single expression vector. For this purpose we have subcloned a cDNA expression library deriving from human fetal brain (2) into our dual expression T7 vector and investigated 96 randomly picked clones. After sequencing, 29 clones in the correct reading frame have been identified, their plasmids isolated and shuttled from yeast to bacteria. All proteins were expressed soluble in P. pastoris, whereas in E. coli only 31% could be purified under native conditions. Our data indicates that this dual expression vector allows the economic expression and purification of proteins in different hosts without subcloning.     

新型双基因表达盒真核载体的构建及功能验证

目的: 构建含双基因表达盒的新型基因疫苗真核表达载体pVAX2,并对其功能进行验证。方法: 设计一个包含人巨细胞病毒启动子(CMV promoter)、T7启动子、信号肽基因、血凝素A表位基因(HA)、多克隆位点区域(MCS)、c-myc抗原表位、血小板来源的生长因子受体跨膜区域(PDGFR TM)及牛生长激素多腺苷酸化信号(BGH polyA)等八种元素的表达盒Ⅱ(Expressing cassette Ⅱ),在其上下游添加Nru Ⅰ酶切位点后,进行人工化学合成,连接到克隆载体pGH中得pGH-Ⅱ;用Nru Ⅰ酶切pGH-Ⅱ,回收1 300bp左右的片段,去磷后插入到pVAX1的相应位点,Nru Ⅰ及Bgl Ⅱ/Pst Ⅰ酶切鉴定,获得新型基因疫苗真核表达载体pVAX2;然后以增强型绿色荧光蛋白(EGFP)为报告基因,将其分别构建至两个不同的表达盒内,脂质体转染BHK-21细胞,利用RT-PCR及荧光显微镜技术进行该载体的功能验证。结果: 两个表达盒内的EGFP基因在BHK-21细胞均能高效表达,相互间不受影响,且新构建的表达盒具有蛋白展示功能。结论: 成功构建含双基因表达盒的新型基因疫苗真核表达载体pVAX2,为多价DNA疫苗的研究奠定了坚实基础。     

The polyester polyurethanase gene (pueA) from Pseudomonas chlororaphis encodes a lipase

A gene (pueA, polyurethane esterase A) encoding an extracellular polyurethanase (PueA) was cloned from Pseudomonas chlororaphis into Escherichia coli. The enzyme secreted from E. coli showed esterase activity when assayed with p-nitrophenyl acetate. Subcloning of a 3. 2-kb SalI-EcoRI fragment into a T7 RNA polymerase expression vector (pT7-6) produced a (35)S-labeled protein of 65 kDa. Nucleotide sequencing of pueA showed an open reading frame encoding a 65-kDa protein of 617 amino acid residues, with the serine hydrolase consensus sequence GXSXG. PueA was over-expressed using the pT7-6 vector transformed into E. coli BL21(DE3) and was purified in one step using Sephadex G-75.     

HBV X基因的表达及在真核细胞中对内质网压力的作用

运用PCR技术获得HBx基因,分别克隆到原核表达载体pET-his和真核表达载体pcDNA3.1(-)上。重组质粒pET-his-HBx转化大肠杆菌BL21(DE3)后,IPTG诱导表达,利用Ni柱纯化后的蛋白免疫家兔,获得特异性的抗-HBx兔抗血清。重组质粒pcDNA3.1(-)-HBx分别转染HepG2和Hep3B细胞系后,经RT-PCR和Westernblot检测,证明HBx可以在这两种细胞系中表达。通过报告基因的表达研究了HBx对XBP1和GRP78启动子的激活活性,结果表明瞬时转染HBx的细胞系中,XBP1和GRP78启动子介导的荧光素酶活性比相应的对照细胞增加了3～7倍。通过RT-PCR分析证明,转染了HBx的细胞中XBP1mRNA发生了剪切。因此,可以初步推断HBx在HepG2和Hep3B细胞中的表达可以引起内质网压力反应,为进一步阐明HBx表达对内质网的影响和肝脏病原发生机制奠定了基础。     

一种带增强子的原核高效表达载体的构建及初步应用

构建的pTO-T7大肠杆菌高效融合表达载体,调控序列中有一个Ω序列和一个T7启动子串联;多克隆位点(MCS)包括8个常用酶切位点;可进行融合表达或者非融合表达,根据不同的需要加以选择;融合蛋白N端为T7g10的12个起始氨基酸,C端为His标签;含kan抗性基因作为选择标记。将增强型绿色荧光蛋白(EGFP)基因克隆至pTO-T7载体,在E.coli中的表达结果表明,融合EGFP达到菌体总蛋白量的50%以上,90%以上的融合蛋白以可溶性形式存在,融合后的EGFP仍保持原有的荧光性质。与同时构建的不含Ω序列的pT-T7载体的表达产量的比较研究结果表明,Ω序列在pTO-T7载体中能显著提高表达效率。     

IL-1023-57-PE40可溶表达、纯化及其细胞活性

以IL-10的功能短肽(35肽,即IL10第23至57氨基酸残基)为导向部分与PE40(绿脓杆菌外毒素除去受体结合区后的剩余部分)融合分别置入pet20b( )和pet28a( )构建重组毒素IL102357PE40的两种表达质粒,其中置于pet20b( )的重组毒素在BL21(DE3)pLysS中以周质分泌可溶形式表达,置于pet28a( )的重组毒素在Rosettablue(DE3)中以高效胞质可溶形式表达;依次通过硫酸铵盐析、疏水层析、阴离子交换层析、铜离子亲和层析纯化周质分泌成份,得90%重组毒素纯品;细胞活性实验表明,该重组毒素只对单核巨噬细胞有杀伤作用;细胞ELISA显示,该重组毒素对单核巨噬细胞的杀伤作用(IC50为13.9pmolL)符合绿脓杆菌外毒素的作用机理.     

Expression of the hepatitis B virus surface antigen in Drosophila S2 cells

Drosophila melanogaster S2 cells were transfected with a plasmid vector (pAcHBsAgHy) containing the S gene, coding for the hepatitis B virus surface antigen (HBsAg), under control of the constitutive drosophila actin promoter (pAc), and the hygromycin B (Hy) selection gene. The vector was introduced into Schneider 2 (S2) Drosophila cells by DNA transfection and a cell population (S2AcHBsAgHy) was selected by its resistance to hygromycin B. The pAcHBsAgHy vector integrated in transfected S2 cell genome and approximately 1,000 copies per cell were found in a higher HBsAg producer cell subpopulation. The HBsAg production varied in different subpopulations, but did not when a given subpopulation was cultivated in different culture flasks. Higher HBsAg expression was found in S2AcHBsAgHy cells cultivated in Insect Xpress medium (13.5 μg/1E7 cells) and SFX medium (7 μg/1E7 cells) in comparison to SF900II medium (0.6 μg/1E7 cells). An increase of HBsAg was observed in culture maintained under hygromycin selection pressure. Data presented in the paper show that S2AcHBsAgHy cells produce efficiently the HBsAg which is mainly found in the cell supernatant, suggesting that HBsAg is secreted from the cells. The data also show that our approach using the Drosophila expression system is suitable for the preparation of other viral protein preparation.     

小鼠白细胞介素33真核表达质粒的构建及表达

克隆小鼠IL-33基因构建其真核表达质粒,并转染COS-7细胞检测其表达。提取C57BL/6小鼠肺组织总RNA,经反转录聚合酶链式反应（RT-PCR）扩增小鼠IL-33基因,酶切后插入pcDNA^TM3.1/myc HisA构建其真核表达质粒pcDNA-3.1-IL-33,重组质粒转染COS-7细胞,RT-PCR和免疫印迹法（western blotting）检测目的基因表达。结果显示,pcDNA3.1-IL-33中插入的片段序列测定结果与小鼠IL-33cDNA序列一致,重组质粒转染COS-7细胞后检测到相应mRNA及蛋白表达。成功克隆了小鼠IL-33基因cDNA,并构建其真核表达质粒。     

Expression and characterization of a recombinant yeast isoleucyl-tRNA synthetase

We describe the heterologous expression of a recombinant Saccharomyces cerevisiae isoleucyl-tRNA synthetase (IRS) gene in Escherichia coli, as well as the purification and characterization of the recombinant gene product. High level expression of the yeast isoleucyl-tRNA synthetase gene was facilitated by site-specific mutagenesis. The putative ribosome-binding site of the yeast IRS gene was made to be the consensus of many highly expressed genes of E. coli. Mutagenesis simultaneously created a unique BclI restriction site such that the gene coding region could be conveniently subcloned as a "cassette." The variant gene was cloned into the expression vector pKK223-3 (Brosius, J., and Holy, A. (1984) Proc. Natl. Acad. Sci. U.S.A. 81, 6929-6933) thereby creating the plasmid pKR4 in which yeast IRS expression is under the control of the isopropyl-thio-beta-galactopyranoside (IPTG)-inducible tac promoter. Recombinant yeast IRS, on the order of 10 mg/liter of cell culture, was purified from pKR4-infected and IPTG-induced E. coli strain TG2. Yeast IRS was purified to homogeneity by a combination of anion-exchange and hydroxyapatite gel chromatography. Inhibition of yeast IRS activity by the antibiotic pseudomonic acid A was tested. The yeast IRS enzyme was found to be 10(4) times less sensitive to inhibition by pseudomonic acid A (Ki = 1.5 x 10(-5) M) than the E. coli enzyme. E. coli strain TG2 infected with pKR4, and induced with IPTG, had a plating efficiency of 100% at inhibitor concentrations in excess of 25 micrograms/ml. At the same concentration of pseudomonic acid A, E. coli strain TG2 infected with pKK223-3 had a plating efficiency less than 1%. The ability of yeast IRS to rescue E. coli from pseudomonic acid A suggests that the eukaryotic synthetase has full activity in its prokaryotic host and has specificity for E. coli tRNA(ile).